Takeda Pharmaceutical's Cash from Investing Activities fell 9641.73% to -$1.5 billion in Q4 2025 from the same period last year, while for Dec 2025 it was -$2.2 billion, marking a year-over-year increase of 1888.87%. This contributed to the annual value of -$2.4 billion for FY2025, which is 2508.28% up from last year.
Takeda Pharmaceutical's Cash from Investing Activities amounted to -$1.5 billion in Q4 2025, which was down 9641.73% from -$326.7 million recorded in Q3 2025.
Over the past 5 years, Takeda Pharmaceutical's Cash from Investing Activities peaked at $2.8 billion during Q1 2021, and registered a low of -$3.3 billion during Q1 2023.
In the last 5 years, Takeda Pharmaceutical's Cash from Investing Activities had a median value of -$461.6 million in 2023 and averaged -$565.6 million.
Data for Takeda Pharmaceutical's Cash from Investing Activities shows a peak YoY increase of 82531.8% (in 2021) and a maximum YoY decrease of 1055469.47% (in 2021) over the last 5 years.
Over the past 5 years, Takeda Pharmaceutical's Cash from Investing Activities (Quarter) stood at -$608.2 million in 2021, then skyrocketed by 45.66% to -$330.5 million in 2022, then tumbled by 54.08% to -$509.2 million in 2023, then crashed by 49.27% to -$760.1 million in 2024, then plummeted by 96.42% to -$1.5 billion in 2025.
Its Cash from Investing Activities was -$1.5 billion in Q4 2025, compared to -$326.7 million in Q3 2025 and -$229.4 million in Q2 2025.

Peer Comparison

Historic Data

Download Data 🔒

Date	Value